Work

Molecular Imaging of Prostate Cancer: Choosing the Right Agent

Year: 2018

Type: article

Abstract: See the associated article on page [789][1]. The well-recognized limitations of conventional imaging with CT, MRI, and 99mTc-methylene diphosphonate bone scans have contributed to a revolution in PET imaging of prostate cancer (PCa). A plethora of PET radiotracers has entered preclinical and early

Source: Journal of Nuclear Medicine

DOI: 10.2967/jnumed.117.206318

Authors: Steven P. Rowe, Martin G. Pomper, Michael A. Gorin

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital

Language: English

Topic: Medical Imaging Techniques and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2790635772